证券代码：920016 证券简称：中草香料 公告编号：2025-027 安徽中草香料股份有限公司 2024 年年度权益分派预案公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 安徽中草香料股份有限公司（以下简称"公司"）为积极履行回报股东义 务，结合公司实际发展情况，根据法律法规及《公司章程》的相关规定，拟定 了 2024 年年度权益分派预案，现将相关事项公告如下： 一、权益分派预案情况 根据公司 2025 年 4 月 18 日披露的 2024 年年度报告（财务报告已经审计）， 截至 2024 年 12 月 31 日，上市公司合并报表归属于母公司的未分配利润为 96,995,559.56 元，母公司未分配利润为 107,222,408.63 元。 公司本次权益分派预案如下：公司目前总股本为 76,981,929 股，以未分配利 润向全体股东每 10 股派发现金红利 0.7 元（含税）。本次权益分派共预计派发现 金红利 5,388,735.03 元。 公司将以权益分派实施时股权登记日应分配股数为基数， ...

证券代码：920016 证券简称：中草香料 公告编号：2025-025 安徽中草香料股份有限公司 一、本人独立性基本情况 本人满云，作为公司独立董事，经自查，本人未在公司担任除独立董事以外 的其他任何职务，未直接或间接持有公司股份，未在公司控股股东、实际控制人 及其附属企业任职，亦不存在其他影响独立性的情况，具备法律法规所要求的独 立性。 二、年度履职情况 （一）出席董事会、股东大会情况 2024 年年度独立董事述职报告（满云） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为安徽中草香料股份有限公司（以下简称"公司"）的独立董事，本人在 职期间严格按照《公司法》《证券法》《北京证券交易所股票上市规则（试行）》 《北京证券交易所上市公司持续监管指引第 1 号——独立董事》《公司章程》《独 立董事工作制度》等相关规定，在 2024 年度工作中诚实、勤勉、独立地履行职 责，积极出席董事会、股东大会等相关会议，认真审议各项议案，切实维护了公 司和股东的利益，较好地发挥了独立董事的作用。现就 2024 年度 ...

证券代码：920016 证券简称：中草香料 公告编号：2025-026 安徽中草香料股份有限公司 2024 年年度独立董事述职报告（何喜桥） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为安徽中草香料股份有限公司（以下简称"公司"）的独立董事，本人在 职期间严格按照《公司法》《证券法》《北京证券交易所股票上市规则（试行）》 《北京证券交易所上市公司持续监管指引第 1 号——独立董事》《公司章程》《独 立董事工作制度》等相关规定，在 2024 年度工作中诚实、勤勉、独立地履行职 责，积极出席董事会、股东大会等相关会议，认真审议各项议案，切实维护了公 司和股东的利益，较好地发挥了独立董事的作用。现就 2024 年度履职情况汇报 如下： 本人何喜桥，作为公司独立董事，经自查，本人未在公司担任除独立董事以 外的其他任何职务，未直接或间接持有公司股份，未在公司控股股东、实际控制 人及其附属企业任职，亦不存在其他影响独立性的情况，具备法律法规所要求的 独立性。 一、本人独立性基本情况 | 次数 | 次数 | ...

证券代码：920016 证券简称：中草香料 公告编号：2025-024 安徽中草香料股份有限公司 2024 年年度独立董事述职报告（唐玮） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为安徽中草香料股份有限公司（以下简称"公司"）的独立董事，本人在 职期间严格按照《公司法》《证券法》《北京证券交易所股票上市规则（试行）》 《北京证券交易所上市公司持续监管指引第 1 号——独立董事》《公司章程》《独 立董事工作制度》等相关规定，在 2024 年度工作中诚实、勤勉、独立地履行职 责，积极出席董事会、股东大会等相关会议，认真审议各项议案，切实维护了公 司和股东的利益，较好地发挥了独立董事的作用。现就 2024 年度履职情况汇报 如下： 一、本人独立性基本情况 本人唐玮，作为公司独立董事，经自查，本人未在公司担任除独立董事以外 的其他任何职务，未直接或间接持有公司股份，未在公司控股股东、实际控制人 及其附属企业任职，亦不存在其他影响独立性的情况。 二、年度履职情况 （一）出席董事会、股东大会情况 2024 ...

Financial Performance - Operating revenue for Q1 2025 reached CNY 47,253,258.03, a growth of 10.36% year-on-year[9] - Net profit attributable to shareholders decreased by 71.60% to CNY 3,823,967.56 compared to the same period last year[9] - Total operating revenue for Q1 2025 reached ¥47,253,258.03, an increase from ¥42,818,736.92 in Q1 2024, representing a growth of approximately 10.1%[32] - Total operating costs for Q1 2025 were ¥42,920,972.75, up from ¥33,582,034.05 in Q1 2024, indicating a rise of about 27.8%[32] - Net profit for Q1 2025 was ¥3,823,967.56, a decrease from ¥13,466,468.02 in Q1 2024, reflecting a decline of approximately 71.6%[33] - The operating profit for Q1 2025 was ¥4,479,568.72, down from ¥9,149,827.67 in Q1 2024, showing a decrease of about 51.0%[33] - Total comprehensive income for Q1 2025 was ¥3,823,967.56, down from ¥13,466,468.02 in Q1 2024, reflecting a decline of approximately 71.6%[33] - The company’s total profit for Q1 2025 was ¥4,479,136.84, down from ¥15,747,177.43 in Q1 2024, indicating a decrease of about 71.5%[33] Cash Flow - Cash flow from operating activities turned negative at CNY -3,911,730.98, a decline of 141.06% year-on-year[9] - The net cash flow from operating activities for Q1 2025 was -3,911,730.98 CNY, compared to 9,526,305.88 CNY in Q1 2024, indicating a significant decline[38] - Total cash inflow from operating activities in Q1 2025 was 56,536,130.04 CNY, while cash outflow was 47,009,824.16 CNY, resulting in a net cash flow of 9,526,305.88 CNY for Q1 2024[38] - Cash inflow from investment activities in Q1 2025 was 19,054,553.01 CNY, while cash outflow was 38,656,920.67 CNY, leading to a net cash flow of -19,602,367.66 CNY[38] - Cash inflow from financing activities in Q1 2025 was 57,132,021.50 CNY, with cash outflow of 25,768,064.40 CNY, resulting in a net cash flow of 31,363,957.10 CNY[38] - The ending cash and cash equivalents balance for Q1 2025 was 60,192,344.95 CNY, compared to 81,401,204.59 CNY at the end of Q1 2024[38] - The company reported a total cash inflow from operating activities of 58,299,296.59 CNY in Q1 2025, slightly up from 56,505,697.27 CNY in Q1 2024[39] - The cash outflow for operating activities in Q1 2025 was 67,107,413.25 CNY, compared to 46,584,321.54 CNY in Q1 2024, reflecting increased operational costs[40] - The net increase in cash and cash equivalents for Q1 2025 was 7,835,501.20 CNY, compared to 20,018,654.43 CNY in Q1 2024[38] Assets and Liabilities - Total assets increased by 6.37% to CNY 605,759,736.15 compared to the end of the previous year[9] - The company's debt-to-asset ratio rose to 38.70% from 35.57% year-on-year[9] - The total current assets as of March 31, 2025, amounted to CNY 216,793,521.34, an increase from CNY 187,437,160.25 as of December 31, 2024, reflecting a growth of approximately 15.6%[26] - Cash and cash equivalents increased to CNY 61,192,344.95 from CNY 53,351,523.62, representing a growth of about 14.5%[26] - Inventory increased by 33.70% to CNY 76,863,269.86, indicating a rise in raw material reserves[10] - The total liabilities decreased from CNY 56,861,000 to CNY 54,030,700, a reduction of about 5.0%[19] - Total liabilities rose to ¥234,436,789.59, compared to ¥202,587,122.95, indicating an increase of about 15.71%[28] - Non-current liabilities increased significantly to ¥81,580,477.35 from ¥50,337,596.23, marking a growth of approximately 62.06%[27] - Current liabilities totaled ¥152,856,312.24, slightly up from ¥152,249,526.72, reflecting a marginal increase of 0.40%[27] - Shareholders' equity reached ¥371,322,946.56, an increase from ¥366,880,874.29, showing a growth of about 1.21%[28] Research and Development - Research and development expenses increased by 76.73% to CNY 2,884,568.59, reflecting higher investment in new technologies[11] - Research and development expenses increased to ¥2,884,568.59 in Q1 2025 from ¥1,632,169.19 in Q1 2024, marking a rise of approximately 76.7%[32] Shareholder Information - The number of ordinary shareholders increased to 4,207, with total shares outstanding remaining at 76,981,929[16] - The number of major shareholders holding more than 5% of shares remains stable, with the largest shareholder, Li Li, holding 40.84%[19] Compliance and Legal Matters - The company has maintained compliance with internal review procedures for major events and disclosures[21] - There were no significant legal disputes or arbitration matters reported during the period[21] - The company has not engaged in any external borrowing activities during the reporting period[21] - The company has not announced any new product developments or market expansions in this reporting period[22]

Company Overview - The total share capital of Anhui Chinaherb Flavors & Fragrances Co., Ltd. is 76,981,929 shares, with no preferred shares issued[23]. - The company went public on September 13, 2024, after issuing 17,192,500 ordinary shares, increasing total shares from 59,789,429 to 76,981,929[23]. - The registered capital of the company is RMB 76,981,929[23]. - The company is listed on the Beijing Stock Exchange under the stock code 920016[19]. - The actual controller of the company is Li Li, with no concerted action parties[22]. - The company has a standard unqualified audit report issued by Zhonghui Certified Public Accountants[13]. - The company has no delisting risk as per the current assessment[15]. Financial Performance - The company's operating revenue for 2024 reached ¥222,152,611.04, representing a year-over-year increase of 7.89% compared to ¥205,907,995.81 in 2023[28]. - The net profit attributable to shareholders decreased by 10.75% to ¥36,626,068.34 in 2024 from ¥41,035,910.44 in 2023[28]. - The total assets increased by 34.74% to ¥569,467,997.24 at the end of 2024, up from ¥422,646,161.25 at the end of 2023[30]. - The company's net assets attributable to shareholders rose by 64.00% to ¥366,880,874.29 in 2024, compared to ¥223,707,882.14 in 2023[30]. - The basic earnings per share decreased by 17.39% to ¥0.57 in 2024 from ¥0.69 in 2023[28]. - The operating cash flow for 2024 was ¥31,003,710.84, a decline of 46.60% from ¥58,059,753.08 in 2023[30]. - The company reported a decrease in the net profit growth rate of 10.75% in 2024, contrasting with an 8.81% increase in 2023[30]. - The company received government subsidies amounting to ¥15,626,976.25 in 2024, significantly higher than ¥4,100,551.11 in 2023[35]. Assets and Liabilities - Accounts receivable increased by 57.58% to ¥43,919,665.26, attributed to unsettled accounts and increased revenue during the reporting period[62]. - Fixed assets grew by 266.33% to ¥225,196,447.00, primarily due to the completion of projects in the herbal new materials sector[62]. - Short-term borrowings rose by 60.38% to ¥83,125,496.09, reflecting the company's increased operational financing needs[62]. - The capital reserve increased by 131.81% to ¥171,394,312.59, mainly due to stock issuance and premium increases[62]. - The company's long-term borrowings decreased by 54.83% to ¥48,775,606.90, as funds raised were used to repay some long-term debts[62]. - The company's employee compensation liabilities increased by 122.23% to ¥3,443,723.50, driven by a rise in workforce and unallocated year-end bonuses[62]. - Deferred tax liabilities increased by 183.76% to ¥69,267.88, reflecting an increase in taxable temporary differences[62]. Research and Development - The company focuses on R&D for new products and processes, with projects like "Efficient Synthesis of Wave Clean Red Aldehyde" completed during the reporting period[53][54]. - The company has expanded its R&D team significantly, increasing the number of master's degree holders from 5 to 9 and bachelor's degree holders from 7 to 25[94]. - R&D expenditure for the current period amounted to ¥9,248,912.31, representing 4.16% of operating revenue, compared to 4.21% in the previous period[92]. - The total number of R&D personnel increased from 18 to 49, with the proportion of R&D staff in total employees rising from 9.52% to 15.61%[94]. - The company has completed laboratory projects on high-efficiency synthesis of Polygodial, aiming for high yield and stable quality, which will enhance its competitiveness in the daily chemical industry[96]. Market and Sales - The company achieved total assets of 569.468 million yuan, an increase of 146.8218 million yuan, representing a growth rate of 34.74%[51]. - The company expanded its overseas sales by 18.80% year-on-year, reflecting efforts to enhance its international market presence[75]. - The company is actively managing raw material price volatility, which significantly impacts production costs, by pre-stocking materials during price increases[111]. - The company is focusing on expanding its market presence by participating in domestic and international industry exhibitions to enhance sales levels[109]. Shareholder Information - Li Li holds 31,438,274 shares, representing 40.84% of the total share capital, making her the controlling shareholder[143]. - The total number of shares held by the top ten shareholders is 56,861,027, accounting for 73.86% of the total share capital[140]. - The company raised a total of RMB 128,943,750.00 through the public offering of 17,192,500 shares, with a net amount of RMB 114,648,634.44 after deducting issuance costs[147]. - The company issued cash dividends of 1.3 yuan per 10 shares, totaling 10,007,650.77 yuan during the reporting period[154]. - The company has a cash dividend policy that aligns with its articles of association and shareholder resolutions, ensuring clarity and compliance[156]. Corporate Governance - The company has not reported any significant fluctuations in the operating performance of its subsidiaries or associated companies[89]. - The company has not engaged in any acquisitions or disposals of subsidiaries during the reporting period[89]. - The company has no incidents of shareholder or related party misappropriation of funds during the reporting period[124]. - The company has ongoing daily related transactions, including purchasing raw materials for 75,221.24 yuan against an estimated 500,000 yuan[124]. Environmental and Social Responsibility - The company has established an environmental management system and is committed to sustainable development and compliance with environmental regulations[105]. - The company is committed to fulfilling its social responsibilities, including supporting poverty alleviation and environmental protection initiatives[104]. Risks and Challenges - The company acknowledges potential uncertainties from macroeconomic changes, trade environment shifts, and intensified industry competition[110]. - The company faces risks of performance not sustaining high growth or even declining due to macroeconomic fluctuations, industry policy changes, and market competition[112].

中草香料公告，2025年一季度营业收入4725.33万元，同比增长10.36%。净利润382.4万元，同比下降 71.60%。 ...

证券代码：920016 证券简称：中草香料 公告编号：2025-021 安徽中草香料股份有限公司 关于完成检维修并复产的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、情况说明 （一）基本情况 安徽中草香料股份有限公司（以下简称"公司"）为保障生产装置安全有效 运行，根据年度生产计划开展了停产检维修相关工作，详见公司于 2025 年 2 月 24 日在北京证券交易所指定信息披露平台（www.bse.cn）披露的《关于公司停产 检维修的公告》（公告编号：2025-017）。 （二）进展情况 近期，公司已完成生产车间检维修相关事务，恢复正常生产。 二、对公司的影响 公司根据年度生产计划对生产车间进行了全面检维修，为后续安全、连续生 产奠定了基础。 特此公告。 安徽中草香料股份有限公司 董事会 2025 年 4 月 7 日 公司将持续关注生产经营情况，依照相关规定及时履行信息披露义务，敬请 广大投资者注意投资风险。 ...

证券代码：920016 证券简称：中草香料 公告编号：2025-020 安徽中草香料股份有限公司 股票解除限售公告 | 企业（有限合 | | | | | | | --- | --- | --- | --- | --- | --- | | 伙） | | | | | | | | 合计 | — | 8,601,969 | 11.17% | 0 | | 注：解除限售原因： | | | | | | 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、本次股票解除限售数量总额为 8,601,969 股，占公司总股本 11.17%，可交易 时间为 2025 年 3 月 20 日。 二、本次股票解除限售的明细情况及原因 单位：股 | | | | 董事、 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 是否为控股 | 监事、 | 本次 | 本次解除 | 本次解除 | 尚未解 | | 序 | 股东姓名或名 | 股东、实际 | 高级管 | 解 ...

Financial Performance - The company's operating revenue for 2024 is approximately ¥222.15 million, representing a year-on-year increase of 7.89%[4] - The net profit attributable to shareholders of the listed company is approximately ¥36.66 million, a decrease of 10.66% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses is approximately ¥23.43 million, down 37.62% year-on-year[4] - The basic earnings per share decreased to ¥0.57, down 16.41% from the previous year[4] Assets and Equity - Total assets at the end of the reporting period are approximately ¥569.53 million, an increase of 34.75% compared to the beginning of the period[4] - Shareholders' equity attributable to the listed company is approximately ¥366.92 million, up 64.02% year-on-year[4] - The company raised funds through a public offering of shares to unspecified qualified investors, contributing to the increase in shareholders' equity[8] Project Development - The company has invested significantly in the construction of a new project for producing 2,600 tons of cooling agents and fragrance raw materials, which began trial production in October 2024[6] - The decline in net profit is primarily attributed to losses of approximately ¥8.90 million from the new materials subsidiary during the project construction and trial production phase[7] - The company emphasizes the importance of the new project for its long-term development and market competitiveness despite short-term profit pressures[8]